Zai Lab Limited Unsponsored ADR ZLAB

24.98 (0.30) (1.19%) as of 25 Sep
Market cap
$2.9B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
789.57 879.67 806.45 1,008.47 1,409.10 1,186.79 275.93 263.30 229.66 83.95
Receivables
106.12 85.18 59.20 39.96 47.47 5.17 3.79 0.09 — —
Inventory
74.75 39.88 44.83 31.62 18.95 13.14 6.01 0.00 — —
Total current assets
1,019.29 1,050.48 939.61 1,124.34 1,500.88 1,216.04 292.46 269.15 230.61 84.09
Property, Plant, Equpment (Net)
47.39 47.96 53.73 57.86 43.10 29.16 21.35 20.49 11.85 1.25
Long-Term Investments
— 3.12 9.22 6.43 15.61 1.28 2.40 3.15 1.65 0.50
Long-term receivables
— 1.35 — — 23.86 22.14 13.74 8.04 5.06 1.38
Goodwill and Intangible Assets (Total)
79.00 58.93 16.46 8.40 9.66 9.44 8.80 0.32 0.02 0.01
Long Term Assets (Tax, Deferred)
3.39 — — — — — — — — —
Long-term assets (Other)
4.17 6.88 2.43 3.60 2.66 1.88 1.33 0.83 0.43 1.69
Total non-current assets
153.10 135.27 96.69 95.80 109.08 81.60 62.69 32.84 19.02 4.82
Total Assets
1,172.38 1,185.75 1,036.30 1,220.14 1,609.96 1,297.64 355.15 301.99 249.63 88.91
Accounts Payable
141.61 100.91 112.99 65.97 126.16 62.64 22.66 37.43 8.97 0.52
Current Part of Debt
204.53 131.71 — 7.05 5.90 5.16 6.45 3.64 — —
Other current liabilities
63.68 58.72 82.97 66.82 60.81 30.20 13.17 7.77 3.07 3.90
Total current liabilities
416.17 299.39 203.07 139.84 192.90 98.04 46.64 48.84 12.07 5.17
Non-current Revenue (Deferred)
27.33 31.43 28.74 21.36 27.49 16.86 2.88 2.06 2.39 0.78
Preferred Shares of Subsidiary (Mandatory, Redeemable)
— — — — — — — — — 134.51
Non-current Liabilities (Other)
— 0.33 0.33 — — 0.00 10.98 — 1.54 —
Total non-current liabilities
40.72 45.47 37.11 34.70 37.10 30.25 13.86 2.06 2.39 135.29
Total liabilities
456.88 344.86 240.18 174.55 230.00 128.29 60.49 50.91 14.46 140.46
Additional Paid In Capital
3,343.47 3,264.30 2,975.30 2,893.12 2,825.95 1,897.47 734.73 498.04 345.27 9.31
Common Stock (Net)
0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Retained Earnings
(2,628.62) (2,453.08) (2,195.98) (1,861.36) (1,418.07) (713.60) (444.70) (249.63) (110.55) (60.17)
Treasury Stock
29.05 20.84 20.84 11.86 4.28 — — — — —
Shareholders Equity (Other)
— — — — — — — — 0.00 0.00
Common Equity (Total)
715.50 840.90 796.12 1,045.60 1,379.96 1,169.35 294.66 251.08 235.17 (51.55)
Shareholders Equity (Total)
715.50 840.90 796.12 1,045.60 1,379.96 1,169.35 294.66 251.08 235.17 (51.55)
Shareholders Equity and Liabilities (Total)
1,172.38 1,185.75 1,036.30 1,220.14 1,609.96 1,297.64 355.15 301.99 249.63 88.91
Shares (Common)
110.64 107.77 97.22 96.02 95.50 87.81 68.24 58.01 49.91 9.66
Shareholders Equity (Tangible)
636.50 781.96 779.66 1,037.19 1,370.30 1,159.91 285.86 250.76 235.15 (51.56)
Net Debt
(585.04) (747.96) (806.45) (1,001.42) (1,403.20) (1,181.63) (269.48) (259.66) (229.66) (83.95)
Total Debt
204.53 131.71 — 7.05 5.90 5.16 6.45 3.64 — —

Fold the line items

In millions of $ except per-share values · columns are period end dates